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Caloric restriction (CR), fasting, and exercise have long been recognized for their neu-
roprotective and lifespan-extending properties; however, the underlying mechanisms of
these phenomena remain elusive. Such extraordinary beneﬁts might be linked to the
activation of sirtuins. In mammals, the sirtuin family has seven members (SIRT1–7), which
diverge in tissue distribution, subcellular localization, enzymatic activity, and targets. SIRT1,
SIRT2, and SIRT3 have deacetylase activity. Their dependence on NAD+ directly links
their activity to the metabolic status of the cell. High NAD+ levels convey neuroprotective
effects, possibly via activation of sirtuin family members. Mitochondrial sirtuin 3 (SIRT3)
has received much attention for its role in metabolism and aging. Speciﬁc small nucleotide
polymorphisms in Sirt3 are linked to increased human lifespan. SIRT3 mediates the
adaptation of increased energy demand during CR, fasting, and exercise to increased
production of energy equivalents. SIRT3 deacetylates and activatesmitochondrial enzymes
involved in fatty acid β-oxidation, amino acid metabolism, the electron transport chain,
and antioxidant defenses. As a result, the mitochondrial energy metabolism increases.
In addition, SIRT3 prevents apoptosis by lowering reactive oxygen species and inhibiting
components of the mitochondrial permeability transition pore. Mitochondrial deﬁcits
associatedwith aging and neurodegenerationmight therefore be slowed or even prevented
by SIRT3 activation. In addition, upregulating SIRT3 activity by dietary supplementation of
sirtuin activating compounds might promote the beneﬁcial effects of this enzyme.The goal
of this review is to summarize emerging data supporting a neuroprotective action of SIRT3
against Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, and amyotrophic
lateral sclerosis.
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INTRODUCTION
Caloric restriction (CR), fasting, and exercise promote neuropro-
tection and extend healthy lifespan in mammals. Reducing food
consumptionwithoutmalnutrition extends the lifespan of rodents
by up to 50% (Weindruch et al., 1986; McCay et al., 1989). Recent
studies suggested these extraordinary beneﬁts may be linked to
upregulation of sirtuins.
Sirtuins were ﬁrst described as NAD+-dependent type III his-
tone deacetylases with yeast Sir2 as its founding member, silencing
gene expression by histone deacetylation (Guarente and Kenyon,
2000). However, mammalian sirtuins target not only histones in
the nucleus but also other proteins in the cytoplasm and mito-
chondria. In mammals, the sirtuin family has seven members
(SIRT1–7), which differ in tissue distribution, subcellular local-
ization, enzymatic activity, and target proteins. SIRT1, SIRT6,
and SIRT7 are present in the nucleus; SIRT2 in the cytoplasm;
and SIRT3, SIRT4, and SIRT5 in mitochondria (Frye, 2000).
Based on sequence homology, SIRT1, SIRT2, and SIRT3 belong
to class I sirtuins and exhibit deacetylase activity. SIRT4 belongs
to class II and has ADP-ribosylation activity; SIRT5 to class III
and has demalonylation and desuccinylation activity; and SIRT6
and SIRT7 to class IV (He et al., 2012). SIRT6 has deacetylase and
ADP-ribosylase activity, while SIRT7 has no reported activity.
Sirtuin enzymatic activity requires NAD+ as a cofactor whose
levels increase by energy stress which occurs, e.g., during fasting,
CR, and exercise. Thus, NAD+ mediates the adaptive response to
low energy by activating sirtuins and their downstream targets.
Sirtuins transform NAD+ to nicotinamide, which acts as a com-
petitive inhibitor of sirtuins by a negative feedback mechanism.
The other breakdown product of NAD+ is O-acetyl-ADP-ribose.
The average lifespan of humans has steadily increased as a result
of advances in medicine and improved living conditions. Despite
this progress, the maximum human lifespan remains constant,
for reasons not entirely clear. Among the aging theories is the
“free radical theory of aging” proposed by Denham Harman in
the 1950s, which attempts to explain the limit on human lifespan
as the result of accumulated damage to proteins, nucleic acids,
lipids, and organelles by free radicals (Harman, 1956; Weissman
et al., 2007; Wong and Cuervo, 2010). Mitochondria are both the
source and target of reactive oxygen species (ROS) in cells includ-
ing superoxide anions, hydrogen peroxide, hydroxyl radicals, and
reactive nitrogen species such as peroxynitrite. Oxidative and
nitrosative stress can evoke irreversible damage to proteins, lipids,
and DNA. As a result, mitochondria have been linked to aging
and age-related diseases (Hall et al., 2001; Singh, 2006). SIRT3
emerged as a protein of particular interest to the aging ﬁeld due
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to its mitochondrial localization and association with exceptional
long lifespan in humans (Hurst et al., 2002). SIRT3 deacetylates
and activates many mitochondrial enzymes involved in fatty acid
β-oxidation, amino acid metabolism, the electron transport chain
(ETC), and antioxidant defenses. Neurons are especially sensi-
tive to insults that result in energy depletion and oxidative stress
(Du et al., 2003). Here, we will review the well-documented roles
of SIRT3 in metabolism and antioxidant defenses, and the new
evidence linking SIRT3 to neuroprotection.
SIRT3 SUBCELLULAR LOCALIZATION
Althoughmost reports indicated an exclusivemitochondrial local-
ization of SIRT3 (Onyango et al., 2002; Shi et al., 2005; Schwer
et al., 2006; Cooper and Spelbrink, 2008; Gurd et al., 2012), others
have argued that SIRT3 is also present in thenucleus and cytoplasm
(Scher et al., 2007; Sundaresan et al., 2008; Shulga et al., 2010;
Iwahara et al., 2012). SIRT3 target proteins were identiﬁed in all
three compartments: nucleus, cytoplasm, and mitochondrion (He
et al., 2012). Thus, the localization and role of SIRT3 in different
cellular compartments is a matter of considerable debate.
Within mitochondria, SIRT3 appears to be localized to the
inner mitochondrial membrane cristae and the matrix (Shi et al.,
2005; Schwer et al., 2006). Additional investigations are needed to
determine whether SIRT3 also targets to the outer mitochondrial
membrane or the intermembrane space.
SIRT3 ISOFORMS
Initial reports indicated that human SIRT3 is present in a full-
length form and short form. Full-length SIRT3 translocates from
the cytoplasm to mitochondria. Once imported into mitochon-
dria, SIRT3 is processed to the short form (Schwer et al., 2006).
Initially only the short, mitochondrial form of human SIRT3 was
thought to exhibit NAD+-dependent deacetylase activity (Schwer
et al., 2006). However, several reports challenged this view and
demonstrated that both the full-length and short form of SIRT3
exhibit deacetylase activity. In agreement, full-length SIRT3 accu-
mulates in the nucleus and deacetylates histones (Lombard et al.,
2007). In cardiomyocytes, full-length mouse SIRT3 is present in
the nucleus and cytoplasm, while the short form is only found
in mitochondria (Sundaresan et al., 2008). SIRT3 deacetylates Ku-
70 in the cytoplasm and thereby prevents pro-apoptotic BAX to
translocate to mitochondria. In addition, three different splice
variants of mouse SIRT3 were discovered (Jin et al., 2009). Two
of these splice variants contain an amino-terminal mitochondrial
targeting sequence (MTS); however, the third form lacks the MTS
(Cooper et al., 2009; Jin et al., 2009). Upon translocation to mito-
chondria, the MTS is cleaved by a matrix processing peptidase to
produce a short form of SIRT3. Without the MTS, SIRT3 fails to
translocate to mitochondria (Schwer et al., 2002).
Sirt3 POLYMORPHISMS
Initial interest in SIRT3 and its role in human agingwas sparked by
the discovery of unique single nucleotide polymorphisms (SNPs)
linked to centenarians (Hurst et al., 2002; Rose et al., 2003; Bellizzi
et al., 2005). Males carrying the G477T transversion in exon 3 of
Sirt3 are healthy and live beyond the average lifespan. However,
this nucleotide transition is silent and does not alter the amino
acid sequence (Rose et al., 2003). Therefore, the mechanism by
which this SNP prolongs life is unknown.
The second SNP involves the variable number tandem repeat
(VNTR) region within intron 5 of Sirt3 (Bellizzi et al., 2005). The
speciﬁcVNTRpolymorphism exhibits improved enhancer activity
and increases Sirt3 expression (Bellizzi et al., 2005). Interestingly,
a strong linkage disequilibrium has been observed between the
VNTR and G477T polymorphism (Bellizzi et al., 2005). Thus, one
can speculate that the two polymorphisms might exhibit coop-
erative effects. Of additional note, Sirt3 maps to a region within
the short arm of chromosome 11 shared by a cluster of longevity
genes, including insulin-like growth factor 2 (IGF2), proinsulin
(INS), and tyrosine hydroxylase (TH). Therefore, it is possible
that Sirt3 shares common regulatory elements with these genes
(Hurst et al., 2002).
Finally, a third SNP in the coding sequence of Sirt3 has been
discovered. Unlike the ﬁrst two SNPs that are linked to increased
lifespan, the third SNP increases the risk for age-related metabolic
syndrome. The particular SNP involves an amino acid substitution
in the conserved deacetylase catalytic region, resulting in lower
SIRT3 deacetylase activity (Hirschey et al., 2011). Taken together,
additional studies are required to investigate how the various SNPs
modify human health and lifespan.
SIRT3 TISSUE-SPECIFIC EXPRESSION
SIRT3 expression is highest in metabolically active tissues includ-
ing the brain, heart, liver, brown adipose tissue (BAT), and
skeletal muscle (Lombard et al., 2007; Ahn et al., 2008; Gurd
et al., 2012). SIRT3 knockout (KO) mice show no obvious phe-
notypic changes, but are prone to age-linked diseases including
metabolic syndrome, cancer, and cardiac failure (Hirschey et al.,
2011). Whether SIRT3 KO mice exhibit neurological defects has
yet to be elucidated. SIRT3 deletion in mice causes hyperacetyla-
tion of mitochondrial proteins and major metabolic defects. Mass
spectrometry revealed that 65% of all proteins in mitochondria
have at least one lysine acetylated in liver tissue of SIRT3 KO mice
(Hebert et al., 2013). By contrast, SIRT4 KO and SIRT5 KO mice
do not exhibit global hyperacetylation of mitochondrial proteins
(Lombard et al., 2007). In fact, SIRT4 and SIRT5 have either no
or only very weak NAD+-dependent deacetylase activity (Verdin
et al., 2010). SIRT4 has ADP-ribosylase activity and SIRT5 has
demalonylase and desuccinylase activities (Haigis et al., 2006; Du
et al., 2011). Therefore, SIRT3 is the key deacetylase in mitochon-
dria. Future studies using conditional, tissue-speciﬁc knock-in or
knockout mice will establish the functions of SIRT3 in tissues such
as the brain.
MITOCHONDRIAL DYNAMICS
Energy homeostasis is a delicate balance between energy supply,
use, and storage. Mitochondria are highly dynamic organelles and
undergo constant cycles of ﬁssion and fusion. This dynamic pro-
cess ismodiﬁed by nutrient supply, linking cellular energy produc-
tionwith energy demands. For example, nutrient excess stimulates
mitochondrial ﬁssion, fragmented mitochondrial morphology,
and an arrest in oxygen consumption, oxidative phosphoryla-
tion, and ATP synthesis. By contrast, nutrient deﬁciency triggers
mitochondrial fusion, elongated mitochondrial morphology, and
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an acceleration of mitochondrial respiration and ATP produc-
tion (Molina et al., 2009; Gomes and Scorrano, 2011; Rambold
et al., 2011; Liesa and Shirihai, 2013). Thus, mitochondrial ﬁs-
sion and fusion is a ﬁne tuned process that controls the switches
of energy production with energy demand, thereby maintaining
homeostasis.
Mitochondrial ﬁssion and fusion is regulated by conserved
large GTPases of the Dynamin family, which exert opposite func-
tions. Fission is mediated by dynamin related protein 1 (DRP1)
while fusion is controlled by optic atrophy 1 (OPA1), mitofusin
1 (MFN1), and mitofusin 2 (MFN2; Arnoult et al., 2005; Misko
et al., 2010). It can be speculated whether increased SIRT1 and
SIRT3 activity during CR, fasting, and exercise enhance energy
metabolism by activating fusion and inhibiting ﬁssion of mito-
chondria. In support, sirtuin activating compounds, e.g., NAD+
and resveratrol, seem to promote a fused mitochondrial mor-
phology. In addition, exercise promotes DRP1 phosphorylation
at serine 637 by protein kinase A (PKA), a process thought to
inhibit DRP1 function and decrease mitochondrial ﬁssion. Future
studies are needed to investigate how mitochondrial ﬁssion/fusion
GTPases are regulated by dietary changes and sirtuins.
Mitochondrial dynamics is also implicated in aging. For exam-
ple, reducing mitochondrial ﬁssion by DRP1 deletion slows aging
and increases lifespan of yeast (Scheckhuber et al., 2007). Simi-
larly, DRP1 inactivation in worm enhances the positive effects of
reduced insulin signaling on lifespan extension (Yang et al., 2011).
Thus, promoting mitochondrial fusion correlates with longevity
of these model organisms. Whether mitochondrial dynamics
regulates the aging process inmammals remains to be investigated.
A balance between mitochondrial ﬁssion and fusion plays a
critical role in neuronal function and survival (Knott et al., 2008).
In neurons, mitochondrial dynamics is required for bioenergetic
and synaptic function, Ca2+ buffering, transport of mitochondria
across neurites, removal of damaged mitochondria by autophagy,
and neuronal cell survival. Future studies are needed to investigate
whether SIRT3 enhances neuronal survival by regulating processes
such as mitochondrial ﬁssion and fusion.
SIRT3 IN CR AND EXERCISE
More than 70 years ago the lifespan-extending properties of a CR
diet were demonstrated in rats (McCay et al., 1989). The details
of this observation were not further explored until almost half a
century later whenWalford andWeindruch discovered that reduc-
ing food consumption 25–60% without malnutrition extends the
lifespan of mice up to 50% (Weindruch et al., 1986). More recently,
CR has been shown to inhibit neurodegeneration in animal mod-
els of both Alzheimer’s disease (AD) and Parkinson’s disease (PD;
Zhu et al., 1999; Mattson, 2000). A deeper look into the metabolic
and cellular changes that occur during metabolic stresses such as
CR may reveal the unique mechanisms by which these beneﬁts are
conferred.
During the transition from the fed to fasted state, blood glu-
cose levels decline causing carbohydrate utilization and fatty acid
synthesis to cease in the liver, while fatty acid oxidation and keto-
genesis are induced (McGarry and Foster, 1980). Furthermore,
prolonged starvation results in increased amino acid catabolism as
cells search for a new source of energy. Autophagy is also increased
during nutrient stress (Kuma et al., 2004). Blocking autophagy
accelerates cell death, aging, and neurodegeneration (Kuma et al.,
2004; Hara et al., 2006; Komatsu et al., 2006). Interestingly, NAD+
levels greatly increase during CR in muscle and white adipose
tissue (WAT), thus suggesting potential upregulation of Sirtuin
activity (Chen et al., 2008).
Remarkably, SIRT3 expression levels ﬂuctuate with diet.
Numerous studies have reported CR-induced increased SIRT3
expression (Palacios et al., 2009; Tauriainen et al., 2011). For exam-
ple, mice on a 12-month CR diet exhibited increased SIRT3 levels
in skeletal muscle compared to mice fed ad libitum (Palacios
et al., 2009). In addition, Sirt3 mRNA expression was increased
in liver, skeletal muscle, and adipose tissue of mice on a 30% CR
diet (Tauriainen et al., 2011). By contrast, a chronic high fat diet
(HFD) resulted in suppression of SIRT3 and elevated global mito-
chondrial protein acetylation (Hirschey et al., 2011). Akin to CR,
exercise training in mice increased SIRT3 protein expression in
cardiac and triceps muscles (Palacios et al., 2009).
SIRT3 expression is also modulated during aging. Notably,
elderly individuals exhibited a 50% reduction in peroxisome-
proliferator activated receptor gamma coactivator 1-alpha (PGC-
1α) and SIRT3 protein levels in skeletal muscle compared to
young subjects, regardless of activity level (Joseph et al., 2012).
By contrast, another study suggested exercise training could sus-
tain equivalent levels of SIRT3 in skeletal muscle of both young
and elderly individuals (Lanza et al., 2008). Additional studies are
required to elucidate the mechanisms of these observations. One
possible explanation for reduced SIRT3 levels during aging may be
epigenetic regulation of the Sirt3 gene promoter. Further investi-
gation is required to determine the cause of SIRT3 downregulation
during aging.
SIRT3 IN MITOCHONDRIAL BIOGENESIS
Caloric restriction or exercise induce PGC-1α, a master regulator
of genes involved in mitochondrial biogenesis, metabolism, sup-
pression of ROS, and stress responses (Herzig et al., 2001; Yoon
et al., 2001; Palacios et al., 2009). The importance of PGC-1α in
these processes is underscored by observations of PGC-1α KO
mice, which exhibit many defects including obesity, neurodegen-
eration, cardiomyopathy, and heightened sensitivity to ROS (Lin
et al., 2004; St-Pierre et al., 2006).
Interestingly, PGC-1α may play a role in controlling Sirt3 gene
expression. A sequence motif in the Sirt3 promoter is recognized
by the estrogen related receptor-alpha (ERRα), an orphan nuclear
receptor upregulated in CR (Ranhotra, 2009). PGC-1α mediates
ERRα binding to this sequence motif in the Sirt3 promoter and
promotes Sirt3 gene expression. Additionally, siRNA knockdown
of PGC-1α reduces SIRT3 expression (Kong et al., 2010).
SIRT3 may also upregulate PGC-1α through a positive feed-
back mechanism (Figure 1). SIRT3 deacetylates and activates
liver kinase B1 (LKB1) in cardiomyocytes (Pillai et al., 2010).
Active LKB1 phosphorylates and stimulates AMP-activated pro-
tein kinase (AMPK; Woods et al., 2003). As a result, activated
AMPK phosphorylates cyclic AMP response element binding pro-
tein (CREB) leading to increased PGC-1α expression (Bergeron
et al., 2001; Zong et al., 2002; Thomson et al., 2008). More-
over, AMPK can directly phosphorylate and activate PGC-1α,
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FIGURE 1 | Cellular stress activates SIRT3. Energy deﬁcits resulting from
calorie restriction, exercise, and fasting cause the cellular AMP:ATP ratio to
increase. Increased levels of AMP trigger activation of AMPK, initiating a
signaling cascade promoting SIRT3 expression. SIRT3 promotes activation
of antioxidant systems, fatty acid oxidation, and neuroprotection. A positive
feedback mechanism is also initiated via the deacetylation and activation of
LKB1 by SIRT3, further promoting activation of AMPK. AMPK,
AMP-activated protein kinase; CREB, cyclic AMP response element-binding
protein; PGC-1α, peroxisome proliferator-activated receptor gamma
coactivator 1-alpha; LKB1, liver kinase B1; AMP, adenosine-5′-monophos-
phate; ATP, adenosine-5′-triphosphate.
adding additional stimulatory mechanisms to this pathway
(Jäger et al., 2007).
NAD+ LEVELS GOVERN SIRT3 ACTIVITY
The rate-limiting factor of SIRT3 activity is the availability of
NAD+, a required cofactor for functional deacetylase activity
of the enzyme. Interestingly, the ratio of NAD+ to NADH is
directly linked to cellular energy status, implicating SIRT3 as a
key metabolic sensor (Kim et al., 2006). SIRT3 reacts with NAD+
and an acetylated protein substrate to produce nicotinamide
(NAM), O-acetyl ADP ribose, and the deacetylated substrate
(Onyango et al., 2002). Recycling of NAM to NAD+ is facilitated
by nicotinamide phosphoribosyltransferase (Nampt), also known
as visfatin (Rongvaux et al., 2002). Interestingly, Nampt expres-
sion increases upon fasting, thus further enhancing the activity
of SIRT3 in mitochondria by almost doubling the local NAD+
concentration (Yang et al., 2007). By contrast, surplus energy,
as is available under a HFD, reduces the NAD+/NADH ratio
and thereby inadvertently decreases SIRT3 function (Kim et al.,
2011a).
Aside from the sirtuins, a major consumer of NAD+ in the
cell is poly (ADP-ribose) polymerase (PARP), an enzyme involved
in DNA repair. PARP1-mediated NAD+ depletion is linked with
neurodegeneration (Alano et al., 2004). Furthermore, activation of
PARP1 in PD models contributes to neuronal apoptosis (Outeiro
et al., 2007). However, PARP1 is located in the nucleus, which has
its own separate pool of NAD+, and therefore, its deletion may not
affect SIRT3 activity inmitochondria (Bai et al., 2011). Despite this
compartmentalization, the activity of PARP1 may be indirectly
regulated by the antioxidant function of SIRT3. Decreases in ROS
caused by SIRT3 activity may reduce DNA damage and thereby
reduce PARP1-mediated consumption of NAD+.
SIRT3 ACTIVATES ANTIOXIDANT DEFENSES
Over 90% of cellular ROS is produced by mitochondria as elec-
trons escape the ETC to combine with molecular O2 producing
superoxide anions (O•−2 ; Finkel and Holbrook, 2000). Free radi-
cals such as superoxide and H2O2 can cause considerable oxidative
damage to proteins, lipids, and DNA, consequently expediting
aging, cancer, and neurodegeneration (Balaban et al., 2005). Addi-
tionally, the detrimental effects of ROS become more pronounced
with age due to the limits of cellular antioxidant defense systems.
Mitochondrial ROS production increases in brains of aged mice
(Sawada and Carlson, 1987). Similarly, as humans age there is a
progressive trend toward a pro-oxidant state, perhaps as the cel-
lular ROS defenses cannot keep pace with the steady, age-related
increase in ROS production (Rebrin and Sohal, 2008). This notion
is especially important for neurons that are highly susceptible to
oxidative stress. Progressive ROS accumulation in neurons can
result in exacerbated protein aggregation, cell death, and onset of
neurodegeneration (Du et al., 2003).
The importance of ROS in aging is well illustrated by studies
involving overexpression of antioxidant enzymes. In one partic-
ular study, overexpression of manganese superoxide dismutase
(MnSOD) in Drosophila resulted in prolonged lifespan (Sun et al.,
2002). Likewise, overexpression of catalase increased the lifespan
of mice by 20% (Schriner et al., 2005). Interestingly, SIRT3 activ-
ity can reduce ROS levels by directly modulating key antioxidant
enzymes, thereby acting as a shield against oxidative damage.
To date, the known antioxidant effects of SIRT3 are medi-
ated by its interaction with MnSOD and isocitrate dehydrogenase
2 (IDH2; Figure 2). MnSOD is the primary mitochondrial
antioxidant enzyme that converts O•−2 to H2O2, which is fur-
ther converted to water by catalase (Spitz and Oberley, 1989).
SIRT3 directly deacetylates MnSOD in mitochondria, signiﬁcantly
enhancing its ability to scavenge ROS (Qiu et al., 2010; Tao et al.,
2010). SIRT3 also deacetylates IDH2, causing an increase in its
activity (Mailloux et al., 2007; Someya et al., 2010; Yu et al., 2012).
IDH2 is an enzyme of the tricarboxylic acid cycle which produces
NADPH, a molecule implicated in the regeneration of antiox-
idants (Figure 2). Brieﬂy, glutathione (GSH) acts as a major
antioxidant in cells, reducing thiol groups of oxidized proteins
and serving as mediator of oxidative stress responses (Berndt et al.,
2007). Oxidized glutathione (GSSG) can be regenerated to GSH
by glutathione reductase, an enzyme that is NADPH dependent
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FIGURE 2 | SIRT3 promotes ROS defense systems. SIRT3 deacety-
lates and activates MnSOD and IDH2, increasing their activity. MnSOD
scavenges superoxide produced by the respiratory complexes, converting
it to hydrogen peroxide which is further converted to water. Activation
of IDH2 by SIRT3 increases its activity, thus producing more NADPH for
use by glutathione reductase. GR converts oxidized glutathione to its
reduced form, which is further used by GPX to convert the reactive
hydrogen peroxide into water. O2, molecular oxygen; O
•−
2 , super-
oxide; MnSOD, manganese superoxide dismutase; H2O2, hydrogen
peroxide; CAT, catalase; GPX, glutathione peroxidase; GSH, reduced
glutathione; GSSG, oxidized glutathione; GR, glutathione reductase;
NADP+, nicotinamide adenine dinucleotide phosphate; NADPH, reduced
nicotinamide adenine dinucleotide phosphate; IDH2, isocitrate
dehydrogenase 2.
(Anderson, 1998). Enhanced activity of IDH2 by SIRT3-mediated
deacetylation produces increased levels of NADPH, which in turn
can increase the activity of glutathione reductase to further facili-
tate regeneration of GSH from GSSG (Figure 2). During aging,
oxidized glutathione accumulates and alters the mitochondrial
GSH to GSSG ratio. Therefore, the ratio of GSH to GSSG can be
used as marker for both cellular oxidative stress and aging (Rebrin
et al., 2003).
The relevance of SIRT3 in antioxidant defense systems is evi-
dent in studies of mice under CR conditions. Accordingly, CR
prevented age-related hearing loss in mice by increasing the mito-
chondrial GSH:GSSG ratio inwild-typemice, but not in SIRT3KO
mice (Someya et al., 2010). In another study, CR led to decreased
ROS and increased cell survival by SIRT3-mediated deacetylation
and activation of MnSOD (Qiu et al., 2010).
Aging and neurodegeneration are linked with increased oxida-
tive stress and mitochondrial DNA (mtDNA) mutations. Trans-
genic mice expressing a proofreading-deﬁcient mitochondrial
polymerase gamma (Polγ), also known as mutator mice, exhibit
increased mtDNA mutation rates, mitochondrial dysfunction,
multisystem degeneration, and premature aging (Trifunovic et al.,
2004). Remarkably, endurance exercise of the mice was able
to entirely abolish the accumulation of mtDNA mutations and
the premature aging phenotype (Safdar et al., 2011). The under-
lying mechanisms how exercise eradicates the accumulation of
mtDNA mutations in these mice remain unknown. It is possi-
ble that exercise activates PGC1-α and SIRT3. Increased SIRT3
then lowers ROS-mediated mtDNA damage. Consistent with
this idea, SIRT3 was recently found to directly deacetylate 8-
oxoguanine-DNA glycosylase 1 (OGG1), a base excision repair
enzyme located in both the nuclear and mitochondrial com-
partments. SIRT3 deacetylates and stabilizes OGG1, thereby
promoting its capacity to repair mtDNA (Cheng et al., 2013).
Furthermore, aged SIRT3 null mice exhibit increased oxida-
tive stress and loss of mtDNA copies (Kim et al., 2010; Someya
et al., 2010). It would be interesting to test in future experi-
ments whether SIRT3 deletion in Polγ mutant mice abolishes
the exercise-mediated protective effects againstmtDNAmutations
and premature aging.
In addition to increasing the activities of antioxidant systems
such as MnSOD and IDH2, SIRT3 might also promote the tran-
scription of oxidative stress response genes. Members of the fork
head box subgroup O (FOXO) transcription factors regulate cell
metabolism and the response to oxidative stress (Burgering and
Kops, 2002; Accili and Arden, 2004). SIRT3 binds FoxO3a and
promotes the transcription of catalase and MnSOD (Jacobs et al.,
2008). In mouse cardiomyocytes SIRT3 overexpression elevates
the mRNA levels of both MnSOD and catalase (Sundaresan et al.,
2009). Additionally, in response to glucose restriction, FoxO3a
translocates to mitochondria via an AMPK-dependent pathway.
Within the mitochondrial matrix, SIRT3 deacetylates FoxO3a,
allowing it to bind to mtDNA. Together, SIRT3 and FoxO3a
are recruited with RNA polymerase to mtDNA and promote the
upregulation of all 13 mitochondrial-encoded genes. As a result,
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an increase in mitochondrial respiration is observed, thus link-
ing the AMPK–FoxO3a–SIRT3 pathway to the beneﬁcial effects of
CR in mammals (Peserico et al., 2013). Interestingly, the Foxo3a
locus has previously been shown to be associated with longevity,
underscoring its potential relevance in human aging (Willcox et al.,
2008).
MITOHORMESIS
Numerous studies have documented the deleterious effects of
oxidative stress onnucleic acids, proteins, and lipids; however, ben-
eﬁcial effects of ROS have also been reported. Therefore, lowering
ROS with antioxidants may not always be advantageous and may,
contrary to the general belief, accelerate as opposed to slow aging.
For example, administration of antioxidant vitamin C and vita-
min E severely impairs the insulin-sensitizing and beneﬁcial effects
of exercise in humans (Ristow et al., 2009). The exercise-induced
expression of SOD1, MnSOD, and glutathione peroxidase 1 were
prevented by these antioxidants (Gomez-Cabrera et al., 2008; Ris-
tow et al., 2009). Thus, ROS can have both positive and negative
effects on human health. How can these seemingly contracting
observations be reconciled? An explanation might be found in
studies of the mitohormesis.
Hormesis refers to the generally beneﬁcial biological responses
activated upon exposure to low levels of toxins or cellular stres-
sors. Hormesis-stimulating compounds act by eliciting an adaptive
stress response, which in turn conveys resistance to subsequent
higher doses of the same agent (Kirkland,2010). In one study, tran-
sient exposure of neurons to low levels of ceramide were protective
against subsequent exposure to high levels of oxidative stress that
would otherwise have induced cell death (Goodman and Mattson,
1996). Likewise, it can be speculated that the beneﬁts of CR and
exercise involve induction of a hormetic response (Kouda and Iki,
2010). Furthermore, protective stress response genes such as SIRT3
may be part of this hormetic response. However, the amount of
agent required to produce a beneﬁcial hormetic response may vary
for each person depending on their susceptibility to that particular
agent and might depend on genetic and epigenetic factors as well
as age. Such a response can be visualized with an inverted U-curve
or J-curve (Figure 3) speciﬁc to each stressor (Calabrese et al.,
2012). These concepts of “preconditioning” or hormesis repre-
sent a helpful role for ROS promotion of a mitochondrial survival
of the ﬁttest. Low levels of ROS help select for healthy, resilient
mitochondria, while inefﬁcient, suboptimal mitochondria can be
removed (Tapia, 2006).
SIRT3 IN ENERGY METABOLISM
In the transition from the fed to fasted state many metabolic
changes occur. Carbohydrate utilization in the liver ceases and
fatty acid oxidation is upregulated resulting in production of
acetyl-CoA (McGarry and Foster, 1980). Acetyl-CoA generated
in the liver is then converted to acetoacetate, β-hydroxybutyrate,
and acetone through ketogenesis in mitochondria. Ketone bod-
ies released into the bloodstream can then be used for energy by
both heart and brain tissue during starvation conditions (Laffel,
1999). Interestingly, human subjects on a short-term ketogenic
diet exhibited elevated oxidative metabolism and improved ROS
defense (Nazarewicz et al., 2007).
In response to low caloric intake, SIRT3 activates a vast array
of proteins (Figure 4) associated with the Krebs cycle (tricar-
boxylic acid cycle), fatty acid oxidation, amino acid metabolism,
and the ETC. To promote Krebs cycle activity, SIRT3 deacetylates
and activates both IDH2 and succinate dehydrogenase A (SdhA).
Interestingly, SdhA is also a component of the ETC, thus suggest-
ing SIRT3 plays a role in increased respiratory complex II activity.
In one study, SIRT3 KO mice exhibited a 30% reduction in com-
plex II activity in BAT (Finley et al., 2011). SIRT3 also deacetylates
NDUFA9, a subunit of NADH dehydrogenase (complex I), fur-
ther enhancing ETC activity. In support of this idea, SIRT3 KO
mice exhibited less complex I respiration activity. Furthermore,
Sirt3(−/−) mouse embryonic ﬁbroblast (MEF) cells exhibited a
30% reduction in ATP levels (Ahn et al., 2008).
The use of amino acids for energy also becomes important
during starvation conditions. SIRT3 deacetylates and activates
glutamate dehydrogenase (GDH), promoting the conversion of
FIGURE 3 | Hormetic response curve. Within the hormetic zone, mild or
moderate doses of ROS, calorie restriction, and exercise may increase stress
resistance and promote cell survival by invoking transcription of stress
response genes such as Sirt3. Alternatively, high levels of cellular stress can
cause damaging effects leading to cell death. NOEL, no observed effect level;
CR, calorie restriction; ROS, reactive oxygen species.
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FIGURE 4 | Bona fide and suggested SIRT3 substrates.
glutamate to α-ketoglutarate, which can enter the Krebs cycle
(Schlicker et al., 2008; Verdin et al., 2010; Dong et al., 2012).
Additionally, SIRT3 deacetylates and activates ornithine transcar-
bamoylase (OTC), a critical enzyme in the urea cycle. Activation
of the urea cycle could aid in amino acid catabolism during fasting
conditions (Hallows et al., 2011). Remarkably, Sirt3(−/−) MEFs
exhibit accumulation of many amino acids, indicating a defect in
amino acid catabolism (Hebert et al., 2013).
The large amount of acetate released into the blood stream
by liver cells under fasting conditions is utilized mainly by the
heart and skeletal muscle. These tissues express acetyl-CoA syn-
thetase 2 (ACS2), an enzyme which catalyzes the ligation of
acetate and CoA to form acetyl-CoA for use in energy produc-
tion (Fujino et al., 2001). SIRT3 directly deacetylates and activates
ACS2 in mitochondria, thereby promoting this process (Hallows
et al., 2006; Schwer et al., 2006). Ketone body formation is also
regulated by SIRT3 during fasting. SIRT3 deacetylates 3-hydroxy-
3-methylglutaryl CoA synthase 2 (HMGCS2), elevating its activity
and enhancing β-hydroxybutyrate production (Shimazu et al.,
2010). Additionally, SIRT3 promotes the use of triacylglycerols
in the liver by deacetylating and activating long-chain acyl co-
enzymeAdehydrogenase (LCAD). Interestingly,mice lacking Sirt3
exhibit accumulation of fatty acid oxidation intermediates and
triacylglycerols in the liver (Hirschey et al., 2010).
The metabolic role of SIRT3 has also been proposed to extend
to processes such as regulation of mitochondrial protein synthesis,
steroidogenesis, and ATP synthesis. One report found that SIRT3
may associate with themitochondrial ribosomal subunitMRPL10,
thus implicating SIRT3 in regulation of mitochondrial protein
synthesis (Yang et al., 2010). An interaction between SIRT3 and
P450 cholesterol side chain cleavage monooxygenase (P450scc)
has also been suggested. Speciﬁcally, overexpression of SIRT3 may
stabilize P450scc by deacetylation, potentially connecting SIRT3
with steroidogenesis (Li et al., 2012). Additionally, potential reg-
ulation of the F1F0ATPase by SIRT3 has been proposed. A recent
study demonstrated that SIRT3 binds to the oligomycin sensitivity
conferring protein (OSCP), a subunit of the mitochondrial ATP
synthase (Wu et al., 2013).
SIRT3 may also play a role in the response to consumption of
ethanol. The oxidative metabolism of acetaldehyde (derived from
ethanol) is facilitated by mitochondrial aldehyde dehydrogenase 2
(ALDH2), which is also an NAD+-dependent enzyme (Marchitti
et al., 2008). Interestingly, signiﬁcant acetylation of mitochon-
drial proteins is observed in liver tissues of mice fed high ethanol
diets (Fritz et al., 2012). Remarkably, 30 min after acute ethanol
treatment of human aortic endothelial cells (HAECs), the mito-
chondrial NAD+/NADH ratio decreased by 65%, thus potentially
limiting the activities of NAD+-dependent enzymes such as SIRT3.
Additionally, a decrease in the acetylation state of ALDH2 upon
overexpression of SIRT3 suggests ALDH2 is a target of SIRT3;
however, additional studies must be performed to conﬁrm this
interaction (Xue et al., 2012).
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Numerous reports suggest that SIRT3 may act to prevent
metabolic maladies such as insulin resistance, metabolic syn-
drome, andobesity. Mice fed a chronicHFDexhibit elevated global
mitochondrial protein acetylation as a result of suppression of
SIRT3 (Hirschey et al., 2011). This global acetylation of the mito-
chondrial proteome may play a role in HFD-induced liver injury
(Choudhury et al., 2011). Moreover, SIRT3 KO mice exhibited
impaired insulin action due to increased ROS accumulation (Jing
et al., 2011). Finally, PGC-1α KO mice exhibited many metabolic
defects including obesity, cardiomyopathy, and neurodegenera-
tion (Lin et al., 2004). PGC-1α-mediated upregulation of SIRT3
may play a role in preventing such illnesses.
SIRT3 IN NEUROPROTECTION
The large ATP requirements of neurons predispose them to insults
that result in energy depletion, including DNA damage, exci-
totoxicity, and oxidative stress (Sokoloff, 1981; Du et al., 2003).
Within neurons, mitochondria are the main sources of ROS and
energy production, suggesting these specialized organelles are crit-
ical mediators of age-related diseases such as neurodegeneration
(Singh, 2006). Surprisingly, CR reduces neurodegeneration in ani-
malmodels of both PDandAD,possibly via upregulation of SIRT3
(Zhu et al., 1999; Mattson, 2000). Furthermore, overexpression of
SIRT3 has been shown to signiﬁcantly increase neuronal lifespan
(Weir et al., 2012). The antioxidant and metabolic effects medi-
ated by SIRT3 suggest a potential neuroprotective role through
improved mitochondrial function, which subsequently results in
increased neuronal survival and reduced aging effects.
The direct causes of many forms of neurodegeneration remain
unknown, though insults or agents resulting in neuronal cell
death are likely to play a key role. Studies in aged rat brain have
revealed an age-dependent increase in both mitochondrial ROS
production and cytosolic Ca2+ levels (Sawada and Carlson, 1987;
Xiong et al., 2002; Toescu and Vreugdenhil, 2010). Interestingly,
increased levels of ROS and Ca2+ trigger mitochondrial perme-
ability transition pore (mtPTP) formation, an event which can
lead to apoptosis and trigger neurodegeneration (Du and Yan,
2010). Brieﬂy, the mtPTP includes the voltage-dependent anion
channel (VDAC), adenine nucleotide translocator (ANT), and
cyclophilin D (CypD). In response to ROS and increased Ca2+,
binding of CypD to ANT initiates formation of a tunnel-like
structure, which connects the mitochondrial matrix to the cytosol
resulting in the rapid ﬂow of NAD+ from the mitochondria to
the cytosol (Lemasters et al., 2009). Within the cytosol, NAD+
is quickly hydrolyzed by multiple NADases to yield ADP-ribose
and NAM (Zhang et al., 1995; Bernardi, 1999). The frequency
of mtPTP formation may result in the destruction of defective
mitochondria by autophagy or possibly even cell death via apop-
tosis (Kim et al., 2007). Recent studies suggest SIRT3 may be able
to suppress mtPTP formation during aging. In response to CR,
SIRT3 is upregulated and directly deacetylates CypD, preventing
its association withANT and therefore blocking mtPTP formation
(Hafner et al., 2010; Shulga et al., 2010). Additionally, interaction
between CypD and amyloid-β in mitochondria of AD patients
has been reported. Such an interaction caused increased oxidative
stress and increased mtPTP opening, triggering neurodegenera-
tion (Du and Yan, 2010). Upregulation of SIRT3 may be able to
prevent or delay this process, conveying a neuroprotective effect
in AD.
Recent observations also hint at additional neuroprotective
effects of SIRT3 involving regulation of mitochondrial dynamics.
A defective mitochondrial ﬁssion and fusion balance affects mito-
chondrial transport and function, potentially leading to synaptic
dysfunction and neurodegeneration (Knott et al., 2008). In fact,
mutations in the mitochondrial fusion protein OPA1 cause domi-
nant optic atrophy, thereby linking mitochondrial dynamics with
neuronal functionality (Seo et al., 2010). In a recent study, SIRT3
was able to rescue the mitochondrial fragmentation associated
with a model of amyotrophic lateral sclerosis. Speciﬁcally, spinal
cord motor neurons transfected with SOD1G93A displayed an
increase in round fragmented mitochondria in addition to defects
in bi-directional axonal transport and increased cell death. How-
ever, co-expressionwith either SIRT3or PGC-1αwas able to rescue
SOD1G93A-induced mitochondrial fragmentation and improve
cell survival (Song et al., 2012). Interestingly, PGC-1α directly reg-
ulates mitochondrial dynamics by increasing MFN2 expression
(Soriano et al., 2006). It may be that by inducing PGC-1α, ROS is
decreased by the antioxidant stimulating abilities of SIRT3, while
mitochondrial fusion is increased by MFN2. Additionally, PGC-
1α null mice are more sensitive to the neurodegenerative effects of
ROS, further identifying itself and its target genes such as Sirt3 as
potential mediators of neuroprotection (St-Pierre et al., 2006).
In neurons, increased SIRT3 expression has also been reported
in response to oxidative stress (Kim et al., 2011b). Furthermore,
oxidative stress has been shown to upregulate β-secretase activity,
an enzyme associated with AD (Tamagno et al., 2002). In a study
utilizing amousemodel ofAD,Sirt3mRNAupregulationmirrored
spatiotemporal amyloid-β deposition. Additionally, Sirt3 mRNA
was found to be increased in human post-mortem cortex samples
of AD patients (Weir et al., 2012). In this case, it may be that
upregulation of SIRT3 is a compensatory mechanism in neurons
to attempt to protect against the increased oxidative stress that
accompanies AD development and progression.
The ability of CR to induce SIRT3 expression has been well
documented. Additional stimulators of the Sirtuins have also been
proposed, such as resveratrol, a polyphenol found in red wine.
However, the effect of resveratrol on Sirtuin expression remains
controversial. In one study, mice on a 30% CR diet exhibited
increased Sirt3 mRNA levels, while treatment with resveratrol did
not affect Sirt3 expression levels. In light of this ﬁnding, resvera-
trol may be ineffective in mimicking CR-mediated health beneﬁts
(Tauriainen et al., 2011). However, not all hope is lost for the
polyphenol compounds. A recent report found that a resvera-
trol derivative, trans-(−)-ε-viniferin, is able to increase SIRT3
expression and provide protection in cell models of Huntington’s
disease (HD). Speciﬁcally, viniferin treatment of striatal precursor
cells overexpressingmutant huntingtin resulted in increased SIRT3
expression, increased the NAD+/NADH ratio, reduced intracellu-
lar ROS accumulation, and decreased acetylated MnSOD levels.
Additionally, treatment with viniferin increased levels of acti-
vated AMPK and decreased acetylated LKB1, effects which were
shown to require the presence of SIRT3. Thus, Sirt3 is required
for viniferin-mediated neuroprotection in HD models (Fu et al.,
2012).
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CONCLUSIONS AND FUTURE PERSPECTIVES
The beneﬁcial effects of SIRT3 in regulating metabolism and acti-
vating antioxidant defense systems in response to CR and exercise
is apparent. Additionally, while mechanisms by which SIRT3 can
provide neuroprotection are better understood, there are still some
discrepancies among studies that have not been accounted for.
To date, the majority of studies acknowledge the strict local-
ization of active SIRT3 to mitochondria. Despite this, SIRT3
activity has been reported in the nucleus where it plays a role
in associating with Ku-70 to help promote cell survival (Sundare-
san et al., 2008). The discovery of a splice variant in mice that
lacks a MTS might help explain such observations, but further
experiments could help settle any disputes over SIRT3 subcel-
lular localization. Additionally, short-term and long-term CR
appear to have varying effects on SIRT3 expression (Jing et al.,
2011). What should be the recommended level of CR to max-
imally induce SIRT3 expression? Furthermore, the decrease in
SIRT3 expression with age cannot be explained. What transcrip-
tional regulators affect expression of SIRT3 during aging and how
do these factors get turned on or off over time? These questions
remain unanswered and require further investigation. Finally,
recent global mitochondrial protein acetylome studies have been
performed, potentially identifying a myriad of exciting SIRT3
substrates that are not yet known (Hebert et al., 2013). Identi-
ﬁcation of additional bona ﬁde SIRT3 targets will help solidify
our understanding of the role of SIRT3 in neuroprotection and
longevity.
It has been proposed that excessive energy intake can expose
humans to oxidative consequences during the fourth and ﬁfth
decade of life, potentially leading to cognitive decline during later
years (Debette et al., 2011). Conversely, CR can promote healthy
aging and neuroprotection via the actions of SIRT3. However, the
eating habits of the majority of Western civilization are far from
conducive for induction of optimal SIRT3 expression. For this
reason, molecular mimetics of CR are needed to substitute for an
actual decrease in food intake. In addition, novel agents that can
induce a beneﬁcial hormetic response to promote the upregulation
of stress response genes such as Sirt3 may also be of great thera-
peutic value, providing a means for enhancing neuroprotection
and healthy aging.
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